Clinical Trials in Detroit

Showing 16761-16780 of 19,719 trials

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

NCT00688116

An open-label dose escalation study of patients with solid tumors treated with STA-9090 (ganetespib)

Synta Pharmaceuticals Corp.45 participantsStarted Oct 2007

Los Angeles, California, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDPhase 3< 1 mile

Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia

NCT00106288

The purpose of this study is to determine the efficacy and safety of micafungin (FK463) versus liposomal amphotericin B (AmBisome) in treating neutropenic and non-neutropenic patients with confirmed invasive candidiasis or candidemia. Enrollment will include adult and pediatric patients.

Candidiasis

Astellas Pharma Inc637 participantsStarted Jan 2003

Birmingham, Alabama, United States • Orange, California, United States • Denver, Colorado, United States +34 more locations

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia

Find Trials by Condition in Detroit

A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis

A Study of Oral Recombinant Salmon Calcitonin (rsCT) to Prevent Postmenopausal Osteoporosis

A Study to Describe Pediatric Influenza Vaccine Coverage

ACROSS-Cypher Total Occlusion Study of Coronary Arteries 4 Trial

Home-Based Assessment for Alzheimer Disease Prevention

ADNI: Alzheimer's Disease Neuroimaging Initiative

Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery

Efficacy & Safety Study of VESIcare® (Solifenacin Succinate) in Patients Wishing to Switch From Detrol LA® for Treatment of Overactive Bladder

Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics

A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.

Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection

Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML

Efficacy Study of Antiseptic Preoperative Scrubs in Prevention of Postoperative Infections

Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis

Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC

Evaluation of Corneal Epithelial Thickness Mapping

Improving Clinician Communication Skills (ICCS)